The use of cinnamon supplementation in diabetes: Research evidence and expert opinion
Clinical Trials and Bioavailability Research · 2022
DOI: 10.58489/2836-5836/004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Trials and Bioavailability Research, 2022. Verfasst von Aamir Jalal Al-Mosawi.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Dietary supplements have increasingly used in the prevention and treatment of a variety of chronic conditions, During the previous decades, cinnamon have been reported to have a beneficial effects diabetes mellitus patients, and in experimental diabetic animals. The aim of this paper is to review cinnamon research findings relevant to its supplementary use in diabetes. Conclusion: There is convincing research evidence suggesting that cinnamon has at least a weak hypoglycemic effect and an insulin stimulation effect that can contribute to improving insulin sensitivity and reducing serum glycosylated hemoglobin (HbA1C) in type 2 diabetes. Its antioxidant effect can reduce the risks contributing to the development of diabetes.
Zitieren
APA
Al-Mosawi, A. J. (2022). The use of cinnamon supplementation in diabetes: Research evidence and expert opinion. Clinical Trials and Bioavailability Research. https://doi.org/10.58489/2836-5836/004
Vancouver
Al-Mosawi AJ. The use of cinnamon supplementation in diabetes: Research evidence and expert opinion. Clinical Trials and Bioavailability Research. 2022. doi:10.58489/2836-5836/004
BibTeX
@article{AlMosawi2022,
author = {Al-Mosawi, Aamir Jalal},
title = {The use of cinnamon supplementation in diabetes: Research evidence and expert opinion},
journal = {Clinical Trials and Bioavailability Research},
year = {2022},
doi = {10.58489/2836-5836/004}
}
EUVIMED